Summary: Expanded authorization enables use of REGEN-COV for post-exposure prophylaxis (action taken to prevent disease, especially by specified means or against a specified disease) in certain people exposed to a SARS-CoV-2 (COVID-19) infected individual, or who are at high risk of exposure to an infected individual in an institutional setting …continue reading
Today, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. The emergency use authorization allows the Pfizer-BioNTech COVID-19 …continue reading
Today’s announcement that other Western States will be joining California’s review workgroup on COVID-19 adds to the serious questions and concerns that have yet to be addressed by Governor Gavin Newsom. Will Governor Newsom establishment of a panel to review the Food and Drug Administration’s approval process for COVID-19 vaccines, …continue reading